Moderna

Moderna is a commercial-stage biotech specializing in mRNA technology for vaccines and therapies in oncology, cardiovascular, and rare diseases.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2018
Stage of Initial Investment
Series E
Initial Investment Year
2014